4 completed, 2 terminated, 2 withdrawn. 8 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 4, Terminated 2, Withdrawn 2 |
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
Follow Adenocarcinoma of the Lung: new trials by email Literature Review of Adenocarcinoma of the Lung trials Research Report on Adenocarcinoma of the Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung Nivolumab, GM.CD40L Vaccine - Lung Cancer, Adenocarcinoma of the Lung | Phase 1 / Phase 2 | Withdrawn | H. Lee Moffitt Cancer Center and Research Institute | 2018-07-01 | 2019-09-09 | |
| Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology nintedanib-nivolumab combination therapy - Adenocarcinoma of the Lung | Phase 1 / Phase 2 | Completed | AIO-Studien-gGmbH | 56 | 2018-05-25 | 2024-02-06 |
| Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer soy isoflavones, cisplatin, etoposide - Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer | Phase 1 | Completed | Barbara Ann Karmanos Cancer Institute | 11 | 2014-08-01 | 2020-11-23 |
| Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC Paclitaxel, image-guided adaptive radiation therapy, carboplatin - Adenocarcinoma of the Lung, Large Cell Lung Cancer | Phase 1 | Withdrawn | Virginia Commonwealth University | 2014-03-01 | 2015-03-19 | |
| Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer erlotinib hydrochloride, Hsp90 inhibitor AUY922, laboratory biomarker analysis - Adenocarcinoma of the Lung, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Northwestern University | 38 | 2011-04-27 | 2019-09-11 |
| Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer 3-dimensional conformal radiation therapy, paclitaxel, bevacizumab - Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer | Phase 1 | Terminated | National Cancer Institute (NCI) | 36 | 2006-06-01 | 2014-03-06 |
| Photodynamic Therapy in Treating Patients With Lung Cancer HPPH, photodynamic therapy, therapeutic bronchoscopy - Adenocarcinoma of the Lung, Large Cell Lung Cancer | Phase 1 | Completed | Roswell Park Cancer Institute | 17 | 2004-02-01 | 2014-07-31 |
| Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer cisplatin, etoposide, erlotinib hydrochloride - Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer | Phase 1 | Terminated | National Cancer Institute (NCI) | 48 | 2002-05-01 | 2013-02-01 |
Adenocarcinoma of Lung (8) · Carcinoma, Non-Small-Cell Lung (7) · Adenocarcinoma, Bronchiolo-Alveolar (3) · Adenocarcinoma (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1)
Carcinoma (8) · Neoplasms (8) · Neoplasms by Histologic Type (8) · Neoplasms by Site (8) · Neoplasms, Glandular and Epithelial (8) · Respiratory Tract Neoplasms (8) · Thoracic Neoplasms (8) · Adenocarcinoma (7) · Bronchial Neoplasms (7) · Carcinoma, Bronchogenic (7) · Lung Neoplasms (7) · Respiratory Tract Diseases (7) · Lung Diseases (6) · Neoplastic Processes (1) · Pathologic Processes (1)
Carboplatin (3) · Paclitaxel (3) · Taxes (3) · Cisplatin (2) · Erlotinib Hydrochloride (2) · Etoposide (2) · Radiotherapy (2) · 1-phenyl-3,3-dimethyltriazene (1) · 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (1) · 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide (1) · Bevacizumab (1) · Biopsy, Needle (1) · Docetaxel (1) · Immunotherapy (1) · Nivolumab (1)
National Cancer Institute (NCI) (2) · AIO-Studien-gGmbH (1) · Barbara Ann Karmanos Cancer Institute (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Northwestern University (1) · Roswell Park Cancer Institute (1) · Virginia Commonwealth University (1)
United States (5) · Germany (1)
Ann Mauer (1) · Elisabeth Weiss, MD (1) · Everett Vokes (1) · Jhanelle Gray, M.D. (1) · Martin Reck, Prof. Dr. (1) · Melissa Johnson (1) · Samjot Dhillon (1) · Shirish Gadgeel (1)
N01CM62201 (2), N01CM17102 (1), P30CA014599 (1), P30CA022453 (1)